This spin-out company will exploit the unique platform for the production of growth factors, focusing on the cultured meat and cellular agriculture markets. Additionally, the technology enables the production of specialized enzymes for the innovative healthcare market, with companies focused on cell therapy, gene therapy, and mRNA and DNA synthesis